Paolo A. Ascierto
0000-0002-8322-475X
Publication & Citation Trends
Publications
0 total
Erratum to: Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma. [EJC Skin Cancer, Volume 3, 2025, 100727]
Cited by 0
Semantic Scholar
BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: a stratified, controlled, retrospective EUMelaReg multicenter study
Cited by 0
Semantic Scholar
The performance of the dermoscopic AI score (DEXI) integrated into the VECTRA WB360 imaging system: a clinical-AI-histopathological correlation
Cited by 0
Semantic Scholar
Italian interim analysis of the multinational, post-authorisation safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma: focus on time to onset of adverse events
Cited by 0
Semantic Scholar
The VECTRA WB360 scan for the follow-up of high-risk patients: the performance of the integrated clinical AI algorithm
Cited by 0
Semantic Scholar
Acral lentiginous melanoma shows a poorer response to immune checkpoint inhibition in the non-resectable or metastatic setting – A EUMelaReg real world outcome study
Cited by 1
Semantic Scholar
Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: a retrospective EUMelaReg multicenter study
Cited by 0
Semantic Scholar
Single agent anti-PD-1 versus combined BRAF and MEK inhibitors upfront in metastatic or unresectable BRAF V600 mutated melanoma - A EUMelaReg real world evidence study
Cited by 1
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(801)
Melanoma and MAPK Pathways
(598)
CAR-T cell therapy research
(496)
Cutaneous Melanoma Detection and Management
(391)
Immunotherapy and Immune Responses
(360)
Affiliations
Université Paris-Sud
Roche (Switzerland)
Indiana University Health
Novartis (Switzerland)
The University of Sydney